Keith Michael Gottesdiener, CEO and President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 24,922 shares at $30.02 ($748K) on 2019-02-15, disclosed to the SEC on 2019-02-20.
Open-market sale of $748k RYTM by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.02 | 12,002 | $360K | 48.2% |
| 2 | $30.02 | 12,002 | $360K | 48.2% |
| 3 | $30.05 | 918 | $28K | 3.7% |
| Total | $30.02 avg | 24,922 | $748K | 100% |
| Filing → |
| RYTM | SELL | 2019-02-28 | $128K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |
| RYTM | SELL | 2019-01-24 | $945K | — | Filing → |